These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31522899)

  • 1. Highly Variable Disease Courses in Siblings with Stargardt Disease.
    Valkenburg D; Runhart EH; Bax NM; Liefers B; Lambertus SL; Sánchez CI; Cremers FPM; Hoyng CB
    Ophthalmology; 2019 Dec; 126(12):1712-1721. PubMed ID: 31522899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIBLING CONCORDANCE IN SYMPTOM ONSET AND ATROPHY GROWTH RATES IN STARGARDT DISEASE USING ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE.
    Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; De Roach JN; Azamanov DN; McAllister IL; Constable IJ; Chen FK
    Retina; 2022 Aug; 42(8):1545-1559. PubMed ID: 35344533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric Inter-Eye Progression in Stargardt Disease.
    Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
    Daich Varela M; Laich Y; Hashem SA; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2023 Nov; 130(11):1182-1190. PubMed ID: 37331482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
    Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
    Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Cohort Study of Childhood-Onset Stargardt Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-Onset Disease, and Disease Symmetry.
    Georgiou M; Kane T; Tanna P; Bouzia Z; Singh N; Kalitzeos A; Strauss RW; Fujinami K; Michaelides M
    Am J Ophthalmol; 2020 Mar; 211():159-175. PubMed ID: 31812472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characteristics of late-onset Stargardt's disease.
    Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of fundus abnormalities in Stargardt disease.
    Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study.
    Nishiguchi KM; Ikeda Y; Fujita K; Kunikata H; Akiho M; Hashimoto K; Hosono K; Kurata K; Koyanagi Y; Akiyama M; Suzuki T; Kawasaki R; Wada Y; Hotta Y; Sonoda KH; Murakami A; Nakazawa M; Nakazawa T; Abe T
    Ophthalmology; 2019 Nov; 126(11):1557-1566. PubMed ID: 31257036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy.
    Khan KN; Kasilian M; Mahroo OAR; Tanna P; Kalitzeos A; Robson AG; Tsunoda K; Iwata T; Moore AT; Fujinami K; Michaelides M
    Ophthalmology; 2018 May; 125(5):735-746. PubMed ID: 29310964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-Linked Retinoschisis: Deep Phenotyping and Genetic Characterization.
    Georgiou M; Finocchio L; Fujinami K; Fujinami-Yokokawa Y; Virgili G; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2022 May; 129(5):542-551. PubMed ID: 34822951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients.
    Heath Jeffery RC; Thompson JA; Lo J; Chelva ES; Armstrong S; Pulido JS; Procopio R; Vincent AL; Bianco L; Battaglia Parodi M; Ziccardi L; Antonelli G; Barbano L; Marques JP; Geada S; Carvalho AL; Tang WC; Chan CM; Boon CJF; Hensman J; Chen TC; Lin CY; Chen PL; Vincent A; Tumber A; Heon E; Grigg JR; Jamieson RV; Cornish EE; Nash BM; Borooah S; Ayton LN; Britten-Jones AC; Edwards TL; Ruddle JB; Sharma A; Porter RG; Lamey TM; McLaren TL; McLenachan S; Roshandel D; Chen FK
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):22. PubMed ID: 38743414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLINICAL CHARACTERIZATION OF STARGARDT DISEASE PATIENTS WITH THE p.N1868I ABCA4 MUTATION.
    Collison FT; Lee W; Fishman GA; Park JC; Zernant J; McAnany JJ; Allikmets R
    Retina; 2019 Dec; 39(12):2311-2325. PubMed ID: 30204727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characteristics of childhood-onset Stargardt disease.
    Fujinami K; Zernant J; Chana RK; Wright GA; Tsunoda K; Ozawa Y; Tsubota K; Robson AG; Holder GE; Allikmets R; Michaelides M; Moore AT
    Ophthalmology; 2015 Feb; 122(2):326-34. PubMed ID: 25312043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
    Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features and Genetic Findings.
    Laich Y; Georgiou M; Fujinami K; Daich Varela M; Fujinami-Yokokawa Y; Hashem SA; Cabral de Guimaraes TA; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2024 Jul; 131(7):845-854. PubMed ID: 38278445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
    Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
    Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.